I guess we all would love to see Todos organically increase 100x and go from $0.02 to $2.00 which would take a $2B market cap. I believe the cards are lined up to potentially get there one day, maybe in the next year, depending on how the Dx and Tollovid/r pan out.
But to get to the NASDAQ within say the next 3-4 months, a RS would be in order. RS do work when a company actually has great products, growing revenue, etc. and does it to Uplist
RS don't work when a company does it to stay listed.
RS fail on uplist when a company thinks they have all their ducks in a row, including growing revenue and don't.
I believe Todos will only uplist if the catalysts pre and post uplist are there. Otherwise why wouldn't they just wait? It's going to be pretty obvious if/when they hit those milestones.